From CNBC here:
Mylan said on Monday the auto-injector EpiPen’s pretax profits were 60 percent higher than it told Congress, according to sources close to the matter.
Without a tax-related reduction, the pharmaceutical company’s profits on the EpiPen two-pack would be about $160, higher than the $100 figure the company gave Congress. The company said any lack of clarity was not intentional.
#notintentional or #nottruthful???